查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029年全球阿片类药物使用障碍市场规模研究与预测，按药物类别、给药途径、分销渠道和区域分析。
市场调查报告书
商品编码
1279081

2022-2029年全球阿片类药物使用障碍市场规模研究与预测，按药物类别、给药途径、分销渠道和区域分析。

Global Opioid Use Disorder Market Size study & Forecast, by Drug Class, by Route of Administration, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021年全球阿片类药物使用障碍（OUD）市场价值约为28.8亿美元，预计在2022-2029年预测期内将以超过8.9%的健康增长率增长。阿片类药物是一类镇痛剂，也能放松肌肉、减轻疼痛和缓解压力。为治疗中度至重度疼痛，处方药包括吗啡、氢可酮、羟考酮、可待因、芬太尼、美沙酮和其他药物类阿片。阿片类药物使用障碍（OUD）是一种长期的、复发性的脑部疾病，由过度使用阿片类药物定义，尽管有不良影响。它被归类为一种脑部疾病，因为它涉及到与动机、压力、自我控制和决策相关的大脑回路的功能调整，而且这种调整往往在停止使用毒品后持续很长一段时间。阿片类药物使用障碍的特点是对阿片类药物的强烈渴望，阿片类药物耐受性的上升，以及停药后的戒断症状。市场增长的主要驱动因素是，政府和非政府机构越来越重视，包括癌症、心血管疾病和骨科疾病在内的慢性病发病率不断上升，加上手术干预的发病率激增。

阿片类药物成瘾病例的增加和相关的后果，使全球的市场需求急剧增加。国家药物依赖性治疗中心（NDDTC）的《印度药物使用程度》报告称，2019年2月，目前阿片类药物的使用流行率为2.06%，预计约0.55%的印度人需要治疗阿片类药物使用障碍（有害使用和依赖）。另外，根据美国疾病控制和预防中心，在2020年，美国有近91,799人死于药物过量。年龄调整后的过量死亡率从2019年的每10万人21.6人增加到2020年的每10万人31.1人。(每10万人中有28.3人)。因此，上述这些因素正作为催化因素，促进市场的大幅增长。此外，阿片类药物使用障碍药物的产品发布和产品批准不断增加，以及研发活动的投资不断增加，在预测的几年里呈现出各种利润丰厚的机会。然而，在2022-2029年的预测期内，复杂的报销结构和OUD药物的不良反应正在挑战市场增长。

全球阿片类药物使用障碍（OUD）市场研究考虑的主要地区包括亚太、北美、欧洲、拉美和世界其他地区。北美洲在收入方面占主导地位，因为该地区的政府政策数量不断增加，同时新产品的推出也在增加。而亚太地区在预测期内也将以最高的复合年增长率增长，原因是阿片类药物依赖症患者较多，普通民众对OUD的认识不断提高，以及市场空间中的医疗支出不断增加等因素。

该研究的目的是确定近年来不同领域和国家的市场规模，并对未来几年的价值进行预测。该报告旨在将该行业的定性和定量方面纳入研究范围内的国家。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，并详细分析了竞争格局和主要参与者的产品。.

目录

第一章：执行摘要

  • 市场简介
  • 2019-2029年全球及细分市场的估计和预测
    • 2019-2029年阿片类药物使用障碍（OUD）市场，按地区划分
    • 2019-2029年阿片类药物使用障碍（OUD）市场，按药物类别划分
    • 2019-2029年阿片类药物使用障碍（OUD）市场，按给药途径划分
    • 2019-2029年阿片类药物使用障碍（OUD）市场，按分销渠道划分
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球阿片类药物使用障碍（OUD）市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 研究的范围
    • 行业演变
  • 研究考虑的年份
  • 货币兑换率

第三章：全球阿片类药物使用障碍（OUD）市场动态

  • 阿片类药物使用障碍（OUD）市场影响分析（2019-2029）。
    • 市场驱动力
      • 政府和非政府机构的关注度不断提高
      • 阿片类药物成瘾的案例和相关后果不断增加
    • 市场挑战
      • 复杂的报销结构
      • OUD药物的不良反应
    • 市场机会
      • 阿片类药物使用障碍药物的产品推出和产品批准不断增加
      • 对研发活动的投资不断增加

第四章：全球阿片类药物使用障碍（OUD）市场行业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力模型的未来方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 经济
    • 社会
    • 技术
  • 最佳投资机会
  • 最佳策略
  • 行业专家展望
  • 分析师建议和结论

第五章：风险评估：COVID-19的影响

  • 评估COVID-19对行业的整体影响
  • COVID-19前和COVID-19后的市场情况

第六章：全球阿片类药物使用障碍（OUD）市场，按药物类别划分

  • 市场简介
  • 全球阿片类药物使用障碍（OUD）市场，按药物类别，性能-潜力分析
  • 2019-2029年全球阿片类药物使用障碍（OUD）市场按药物类别的估计和预测
  • 阿片类药物使用障碍（OUD）市场，細項分析
    • 丁丙诺啡
    • 美沙酮
    • 纳曲酮

第7章 ：全球阿片类药物使用障碍（OUD）市场，按给药途径划分

  • 市场简介
  • 全球阿片类药物使用障碍（OUD）市场，按给药途径，性能-潜力分析
  • 2019-2029年全球阿片类药物使用障碍（OUD）市场按给药途径的估计和预测
  • 阿片类药物使用障碍（OUD）市场，細項分析
    • 口服
    • 肠外

第八章：全球阿片类药物使用障碍（OUD）市场，按分销渠道划分

  • 市场简介
  • 全球阿片类药物使用障碍（OUD）市场，按分销渠道划分，业绩-潜力分析
  • 2019-2029年全球阿片类药物使用障碍（OUD）市场按分销渠道的估计和预测
  • 阿片类药物使用障碍（OUD）市场，次级細項分析
    • 医院药房
    • 零售药店和商店
    • 网上药店

第九章：全球阿片类药物使用障碍（OUD）市场，区域分析

  • 阿片类药物使用障碍（OUD）市场，区域市场简介
  • 北美洲
    • 美国
      • 2019-2029年药物类别细分估计和预测
      • 2019-2029年，给药途径的细分估计和预测
      • 2019-2029年分销渠道细分估计和预测
    • 加拿大
  • 欧洲阿片类药物使用障碍（OUD）市场简介
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区阿片类药物使用障碍（OUD）市场简介
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲阿片类药物使用障碍（OUD）市场简介
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 世界其他地区

第十章：竞争情报

  • 顶级市场战略
  • 公司简介
    • MediciNova
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • Indivior PLC
    • Alkermes
    • Orexo AB
    • Titan Pharmaceuticals, Inc.
    • Mallinckrodt Pharmaceuticals
    • BioDelivery Sciences International Inc.
    • Viatris Inc. (Mylan N.V.)
    • Hikma Pharmaceuticals PLC
    • Camurus

第十一章 ：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Opioid Use Disorder (OUD) Market is valued at approximately USD 2.88 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.9% over the forecast period 2022-2029. Opioids are a class of analgesics that also relax muscles, lessen pain, and ease stress. For the treatment of moderate to severe pain, prescriptions are written for drugs including morphine, hydrocodone, oxycodone, codeine, fentanyl, methadone, and other pharmaceutical opioids. Opioid use disorder (OUD) is a long-term, relapsing brain condition defined by excessive opioid use, despite adverse effects. It is classified as a brain condition because it involves functional adjustments to brain circuits associated with motivation, stress, self-control, and decision-making and because such adjustments often last for a long period after drug use has stopped. Opioid use disorder is characterized by an intense desire to take opioids, a rise in opioid tolerance, and withdrawal symptoms following discontinuation. The market growth is primarily driven by the factors such as growing focus of government & non-government institutions, increasing incidences of chronic diseases including cancer, cardiovascular diseases and orthopedic diseases, coupled with the surge in the incidence of surgical intervention.

The rising cases of opioid addiction and related consequences are burgeoning the market demand across the globe. The National Drug Dependence Treatment Centre's (NDDTC) Magnitude of Substance Use in India reported that in February 2019, the prevalence of current opioid use is 2.06%, and approximately 0.55% of Indians are expected to require treatment for opioid use disorders (harmful use and dependence). Also, as per the Centers for Disease Control and Prevention, in 2020, there were nearly 91,799 people died from drug overdoses in the US. Age-adjusted overdose death rates increased from 21.6 per 100,000 in 2019 to 31.1 per 100,000 in 2020. (28.3 per 100,000). Thus, these aforementioned factors are acting as catalyzing factors for market growth at a significant rate. Moreover, the rising product launch and product approval for opioid use disorder drugs, as well as the growing investment in R&D activities are presenting various lucrative opportunities over the forecasting years. However, the complex reimbursement structure and adverse effects of OUD drugs are challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Opioid Use Disorder (OUD) Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising number of government policies, along with increasing new product launches in the region. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as the high presence of patients suffering from opioid dependency, growing awareness amongst the general population regarding OUD, and increasing expenditure on healthcare in the market space.

Major market players included in this report are:

  • MediciNova
  • Indivior PLC
  • Alkermes
  • Orexo AB
  • Titan Pharmaceuticals, Inc.
  • Mallinckrodt Pharmaceuticals
  • BioDelivery Sciences International Inc.
  • Viatris Inc. (Mylan N.V.)
  • Hikma Pharmaceuticals PLC
  • Camurus

Recent Developments in the Market:

  • In February 2021, Orexo AB unveiled that the company entered into a collaborative agreement with ApexB.io and Magellan Rx Management in order to do further study on the usage of Modi. This product is a specially designed digital therapeutic for patients with Opioid Use Disorder.

Global Opioid Use Disorder (OUD) Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Drug Class, Route of Administration, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Class:

  • Buprenorphine
  • Methadone
  • Naltrexone

By Route of Administration:

  • Home
  • Dentistry

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies & Stores
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Opioid Use Disorder (OUD) Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Opioid Use Disorder (OUD) Market, by Drug Class, 2019-2029 (USD Billion)
    • 1.2.3. Opioid Use Disorder (OUD) Market, by Route of Administration, 2019-2029 (USD Billion)
    • 1.2.4. Opioid Use Disorder (OUD) Market, by Distribution Channel, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Opioid Use Disorder (OUD) Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Opioid Use Disorder (OUD) Market Dynamics

  • 3.1. Opioid Use Disorder (OUD) Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing focus of government & non-government institutions
      • 3.1.1.2. Rising cases of opioid addiction and related consequences
    • 3.1.2. Market Challenges
      • 3.1.2.1. Complex reimbursement structure
      • 3.1.2.2. Adverse effects of OUD drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising product launch and product approval for opioid use disorder drugs
      • 3.1.3.2. Growing investment in the R&D activities

Chapter 4. Global Opioid Use Disorder (OUD) Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Opioid Use Disorder (OUD) Market, by Drug Class

  • 6.1. Market Snapshot
  • 6.2. Global Opioid Use Disorder (OUD) Market by Drug Class, Performance - Potential Analysis
  • 6.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
  • 6.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
    • 6.4.1. Buprenorphine
    • 6.4.2. Methadone
    • 6.4.3. Naltrexone

Chapter 7. Global Opioid Use Disorder (OUD) Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Opioid Use Disorder (OUD) Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
  • 7.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Parenteral

Chapter 8. Global Opioid Use Disorder (OUD) Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Opioid Use Disorder (OUD) Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Opioid Use Disorder (OUD) Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
  • 8.4. Opioid Use Disorder (OUD) Market, Sub Segment Analysis
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies & Stores
    • 8.4.3. Online Pharmacies

Chapter 9. Global Opioid Use Disorder (OUD) Market, Regional Analysis

  • 9.1. Opioid Use Disorder (OUD) Market, Regional Market Snapshot
  • 9.2. North America Opioid Use Disorder (OUD) Market
    • 9.2.1. U.S. Opioid Use Disorder (OUD) Market
      • 9.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Opioid Use Disorder (OUD) Market
  • 9.3. Europe Opioid Use Disorder (OUD) Market Snapshot
    • 9.3.1. U.K. Opioid Use Disorder (OUD) Market
    • 9.3.2. Germany Opioid Use Disorder (OUD) Market
    • 9.3.3. France Opioid Use Disorder (OUD) Market
    • 9.3.4. Spain Opioid Use Disorder (OUD) Market
    • 9.3.5. Italy Opioid Use Disorder (OUD) Market
    • 9.3.6. Rest of Europe Opioid Use Disorder (OUD) Market
  • 9.4. Asia-Pacific Opioid Use Disorder (OUD) Market Snapshot
    • 9.4.1. China Opioid Use Disorder (OUD) Market
    • 9.4.2. India Opioid Use Disorder (OUD) Market
    • 9.4.3. Japan Opioid Use Disorder (OUD) Market
    • 9.4.4. Australia Opioid Use Disorder (OUD) Market
    • 9.4.5. South Korea Opioid Use Disorder (OUD) Market
    • 9.4.6. Rest of Asia Pacific Opioid Use Disorder (OUD) Market
  • 9.5. Latin America Opioid Use Disorder (OUD) Market Snapshot
    • 9.5.1. Brazil Opioid Use Disorder (OUD) Market
    • 9.5.2. Mexico Opioid Use Disorder (OUD) Market
    • 9.5.3. Rest of Latin America Opioid Use Disorder (OUD) Market
  • 9.6. Rest of The World Opioid Use Disorder (OUD) Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. MediciNova
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Indivior PLC
    • 10.2.3. Alkermes
    • 10.2.4. Orexo AB
    • 10.2.5. Titan Pharmaceuticals, Inc.
    • 10.2.6. Mallinckrodt Pharmaceuticals
    • 10.2.7. BioDelivery Sciences International Inc.
    • 10.2.8. Viatris Inc. (Mylan N.V.)
    • 10.2.9. Hikma Pharmaceuticals PLC
    • 10.2.10. Camurus

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Opioid Use Disorder (OUD) Market, report scope
  • TABLE 2. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
  • TABLE 4. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
  • TABLE 5. Global Opioid Use Disorder (OUD) Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
  • TABLE 6. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Opioid Use Disorder (OUD) Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. Global Opioid Use Disorder (OUD) Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 17. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. U.S. Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 19. Canada Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 20. Canada Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. Canada Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 22. UK Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 23. UK Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. UK Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 25. Germany Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 26. Germany Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. Germany Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 28. France Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 29. France Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. France Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 31. Italy Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 32. Italy Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Italy Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 34. Spain Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 35. Spain Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. Spain Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 37. RoE Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 38. RoE Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. RoE Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 40. China Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 41. China Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. China Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 43. India Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 44. India Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. India Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 46. Japan Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 47. Japan Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. Japan Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 49. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 50. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. South Korea Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 52. Australia Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 53. Australia Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. Australia Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. RoAPAC Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 58. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 59. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Brazil Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 61. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 62. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. Mexico Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 64. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 65. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. RoLA Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 67. Row Opioid Use Disorder (OUD) Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 68. Row Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. Row Opioid Use Disorder (OUD) Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Opioid Use Disorder (OUD) Market
  • TABLE 71. List of primary sources, used in the study of global Opioid Use Disorder (OUD) Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Opioid Use Disorder (OUD) Market, research methodology
  • FIG 2. Global Opioid Use Disorder (OUD) Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Opioid Use Disorder (OUD) Market, key trends 2021
  • FIG 5. Global Opioid Use Disorder (OUD) Market, growth prospects 2022-2029
  • FIG 6. Global Opioid Use Disorder (OUD) Market, porters 5 force model
  • FIG 7. Global Opioid Use Disorder (OUD) Market, pest analysis
  • FIG 8. Global Opioid Use Disorder (OUD) Market, value chain analysis
  • FIG 9. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Opioid Use Disorder (OUD) Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Opioid Use Disorder (OUD) Market, regional snapshot 2019 & 2029
  • FIG 15. North America Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Opioid Use Disorder (OUD) Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Opioid Use Disorder (OUD) Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable